|
Volumn 249, Issue 1, 2002, Pages 1-8
|
Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis
|
Author keywords
Multiple sclerosis; Urogenital dysfunction; Treatment
|
Indexed keywords
ATROPINE;
BACLOFEN;
BETHANECHOL;
CAPSAICIN;
CARBACHOL;
DICYCLOVERINE;
DOXAZOSIN;
EPHEDRINE;
FLAVOXATE;
GUANETHIDINE;
IMIPRAMINE;
METHACHOLINE;
METHYLDOPA;
NEOSTIGMINE;
OXYBUTYNIN;
PHENOXYBENZAMINE;
PHENYLEPHRINE;
PHENYLPROPANOLAMINE;
PROPANTHELINE BROMIDE;
SILDENAFIL;
TAMSULOSIN;
TERAZOSIN;
TIZANIDINE;
TOLTERODINE;
UNINDEXED DRUG;
URIPASS;
BLADDER;
CLINICAL FEATURE;
DEVICE;
DIAGNOSTIC TEST;
DISEASE COURSE;
ERECTILE DYSFUNCTION;
GENITAL SYSTEM;
GYNECOLOGICAL EXAMINATION;
HUMAN;
HYPERREFLEXIA;
INTERMITTENT CATHETERIZATION;
MICTURITION;
MULTIPLE SCLEROSIS;
NEUROANATOMY;
NEUROPHARMACOLOGY;
NEUROPHYSIOLOGY;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PENIS PROSTHESIS;
PRIORITY JOURNAL;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
REVIEW;
SEX THERAPY;
SEXUAL DYSFUNCTION;
SEXUAL FUNCTION;
SYMPTOM;
TOPICAL TREATMENT;
TREATMENT PLANNING;
URETHRA DISEASE;
UROGENITAL TRACT DISEASE;
|
EID: 0036158873
PISSN: 03405354
EISSN: None
Source Type: Journal
DOI: 10.1007/PL00007835 Document Type: Review |
Times cited : (45)
|
References (15)
|